Letters to the Editor

SIRPαFc treatment targets human acute myeloid leukemia stem cells.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;
Trillium Therapeutics Inc., Mississauga, ON, Canada;
Trillium Therapeutics Inc., Mississauga, ON, Canada;
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Canada;
Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Canada;
Haematologica Early view Feb 13, 2020 https://doi.org/10.3324/haematol.2019.245167